BioCentury
ARTICLE | Financial News

Juno Therapeutics proposes IPO

November 24, 2014 8:00 AM UTC

Juno Therapeutics Inc., Seattle, Wash. Business: Cancer Date announced: 2014-11-17 Type: IPO To be raised: Up to $150 million Shares: TBD Price: TBD Underwriters: Morgan Stanley; JPMorgan; Goldman Sac...